Centaurus Financial, Inc. Bio N Tech Se Transaction History

Centaurus Financial, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	BUY	$122.57 - $153.67 $10,663 - $13,369	87 Added 7.11%	1,311 $163,000
Q4 2022 Feb 10, 2023	SELL	$118.43 - $186.05 $2,487 - $3,907	-21 Reduced 1.69%	1,224 $183,000
Q3 2022 Dec 05, 2022	BUY	$127.65 - $183.11 $1,914 - $2,746	15 Added 1.22%	1,245 $168,000
Q2 2022 Aug 02, 2022	SELL	$123.25 - $186.24 $26,868 - $40,600	-218 Reduced 15.06%	1,230 $183,000
Q1 2022 May 13, 2022	BUY	$126.25 - $231.85 $8,963 - $16,461	71 Added 5.16%	1,448 $247,000
Q4 2021 Feb 01, 2022	BUY	$216.64 - $362.52 $298,313 - $499,190	1,377 New	1,377 $355,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.